Levina Marina, Rubinstein Michael H
School of Pharmacy and Chemistry, John Moores University, Byrom Street, Liverpool L3 3AF, UK.
Drug Dev Ind Pharm. 2002 May;28(5):495-514. doi: 10.1081/ddc-120003446.
An ultrasonic (US) compaction rig has been developed, capable of providing compaction pressure together with high-power ultrasonic vibrations of 20 kHz to a powder or granular material in a die. The rig has been used to investigate the effect of ultrasound on the compaction properties of ibuprofen, a drug with poor compaction properties which produces tablets that are weak and frequently exhibit capping. It was found that coherent ibuprofen tablets could be prepared by ultrasound-assisted compaction at pressures as low as 20-30 MPa. Application of ultrasound before and after compaction was found not to be as effective as ultrasound applied during compaction. The breaking forces of the tablets produced with ultrasound applied during compaction were found to be consistently significantly higher than when compaction was performed conventionally, or with ultrasound applied before or after compaction. Application of ultrasound during compaction made it possible to increase tablet mechanical strength, typically by a factor of 2-5. It was concluded that pressure should be applied together with ultrasound in order to achieve a better acoustical contact, which is required to transmit vibrations from the horn to the material, and also to bond the surfaces of the particles. Ultrasound application during ibuprofen compaction also resulted in an increase in the apparent density, in relation to the apparent density of conventionally prepared tablets, of up to 14.4%. Ultrasound appears to improve particle rearrangement and provides energy for partial melting of particle asperities and subsequent fusion of particle surfaces, so as to increase interparticulate bonding. Solid bridge formation was thought to result in a reduction of void space, which in turn reduced the rate of water penetration into the compacts and consequently increased disintegration and dissolution times. It was found that the results of ultrasound-assisted compaction are influenced by formulation and US time. When ibuprofen was mixed with a second material, such as dibasic calcium phosphate dihydrate (DCP) or microcrystalline cellulose (MCC), stronger tablets were prepared by ultrasound-assisted compaction compared to the compacts containing no filler. Positive interactions were considered to have occurred due to ultrasound-induced bonding between the two materials. With an increase in DCP and MCC concentration in ibuprofen formulations, disintegration and drug dissolution rates of the tablets produced with ultrasound significantly increased. Using temperature-sensitive labels it was found that thermal changes occurred in powdered solids undergoing ultrasound-assisted compaction. Increases in the temperature of tablets were related to US amplitude and US time. With an increase in US amplitude from 5 to 13 microns, the temperature of the DCP tablet surface increased from 40 to 99 degrees C. With an increase in US time from 1 to 5 sec, the temperature of the surface of ibuprofen tablets increased from 43 to 60 degrees C. Increased tablet temperature was thought to be due to ultrasonic energy dissipation turned into heat. X-ray powder diffraction (XRD) studies of ibuprofen tablets prepared by ultrasound-assisted compaction at 32 MPa revealed that no changes in chemical or/and crystalline structure of the material occurred when ultrasound was applied for up to 5 sec (US amplitude 7 microns). An XRD study of DCP tablets produced by ultrasound-assisted compaction at 32 MPa with ultrasound of different amplitudes (5, 7, 13 microns) applied for 2 sec indicated that no material deterioration occurred in all the tested samples.
已经开发出一种超声波(US)压实装置,它能够在模具中对粉末或颗粒材料施加压实压力,并同时施加20kHz的高功率超声波振动。该装置已用于研究超声对布洛芬压实性能的影响,布洛芬是一种压实性能较差的药物,制成的片剂强度较弱且经常出现裂片现象。研究发现,通过超声辅助压实,在低至20 - 30MPa的压力下就可以制备出粘结性良好的布洛芬片剂。结果发现,压实前和压实后施加超声的效果不如压实过程中施加超声的效果好。研究发现,压实过程中施加超声所制备的片剂的断裂力始终显著高于传统压实方式制备的片剂,也高于压实前后施加超声所制备的片剂。压实过程中施加超声能够提高片剂的机械强度,通常提高2 - 5倍。得出的结论是,应将压力与超声一起施加,以便实现更好的声学接触,这是将振动从变幅杆传递到材料并使颗粒表面粘结所必需的。布洛芬压实过程中施加超声还导致表观密度相对于传统制备片剂的表观密度增加高达14.4%。超声似乎改善了颗粒重排,并为颗粒粗糙部分的部分熔化和随后颗粒表面的融合提供能量,从而增加颗粒间的粘结。固体桥的形成被认为导致空隙空间减少,这反过来又降低了水渗透到压实体中的速率,从而延长了崩解和溶解时间。研究发现,超声辅助压实的结果受配方和超声作用时间的影响。当布洛芬与第二种材料,如二水磷酸氢钙(DCP)或微晶纤维素(MCC)混合时,与不含填料的压实体相比,通过超声辅助压实制备的片剂更强。由于两种材料之间超声诱导的粘结作用,认为发生了正相互作用。随着布洛芬配方中DCP和MCC浓度的增加,超声制备的片剂的崩解和药物溶解速率显著增加。使用对温度敏感的标签发现,在进行超声辅助压实的粉末状固体中发生了热变化。片剂温度的升高与超声振幅和超声作用时间有关。随着超声振幅从5微米增加到13微米,DCP片剂表面温度从40℃升高到99℃。随着超声作用时间从1秒增加到5秒,布洛芬片剂表面温度从43℃升高到60℃。片剂温度升高被认为是由于超声能量耗散转化为热量。对在32MPa下通过超声辅助压实制备的布洛芬片剂进行的X射线粉末衍射(XRD)研究表明,当施加超声达5秒(超声振幅7微米)时,材料的化学和/或晶体结构没有变化。对在32MPa下通过超声辅助压实制备的DCP片剂进行的XRD研究,施加不同振幅(5、7、13微米)的超声2秒,结果表明所有测试样品中均未发生材料劣化。